Ohio is third state to fund Pear's digital therapeutics to t...

A third US state has agreed to fund Pear Therapeutics’ digital therapeutics (DTx) to treat people with substance and opioid use disorders. 

Digital therapies for opioid use disorder need more data, sa...

There isn’t enough evidence to suggest that digital therapies for people with opioid use disorder (OUD) can improve on standard interventions, according to the Institute for Clinical and Ec

Pear rolls out digital therapy for schizophrenia under FDA’s...

Sandoz says ‘no’ to Pear Therapeutics’ digital apps, handing...

FDA clears Pear/Sandoz app for opioid use disorder

A second mobile app developed by Pear Therapeutics to help opioid use disorder patients who have a more successful response to therapy has been given a green light by the FDA.